Frontiers | Colorectal Cancer Immunotherapy: Options and Strategies | Immunology
PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting | Business Wire
Oncolytic viroimmunotherapy for colon cancer in clinical trials. | Download Scientific Diagram
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
Checkpoints and beyond – Immunotherapy in colorectal cancer - ScienceDirect
Trial to evaluate combination of CAR-T and pembrolizumab for metastatic colorectal cancer
Biomarkers for precision immunotherapy in the metastatic setting: hope or reality? - ecancer
Clinical Application of Cytokines in Cancer Immunotherapy | DDDT
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
Frontiers | Colorectal Cancer Immunotherapy: Options and Strategies | Immunology
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
Summoning the Troops to Attack Colon Cancer — The Nexus
Genomics and emerging biomarkers for immunotherapy of colorectal cancer - ScienceDirect
New targeted therapy and immunotherapy approaches in Phase I clinical trials | MD Anderson Cancer Center
Frontiers | Colorectal Cancer Immunotherapy: Options and Strategies | Immunology
Advances in cancer immunotherapy 2019 – latest trends | Journal of Experimental & Clinical Cancer Research | Full Text
Clinical trial studies combination immunotherapy for colorectal cancer | Center for Cancer Research
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts - Gastroenterology
Colon Cancer Clinical Trials | Moffitt
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy - Cancer Treatment Reviews
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine
Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges | Oncogenesis
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
Immunotherapy Combination Approved for Colorectal Cancer - NCI
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
